AR102006A1 - Vacunas recombinantes contra el virus de la fiebre aftosa (fmdv) y sus usos - Google Patents
Vacunas recombinantes contra el virus de la fiebre aftosa (fmdv) y sus usosInfo
- Publication number
- AR102006A1 AR102006A1 ARP150103061A ARP150103061A AR102006A1 AR 102006 A1 AR102006 A1 AR 102006A1 AR P150103061 A ARP150103061 A AR P150103061A AR P150103061 A ARP150103061 A AR P150103061A AR 102006 A1 AR102006 A1 AR 102006A1
- Authority
- AR
- Argentina
- Prior art keywords
- fmdv
- polypeptide
- composition
- vaccine
- antigen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462054073P | 2014-09-23 | 2014-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR102006A1 true AR102006A1 (es) | 2017-01-25 |
Family
ID=54256845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150103061A AR102006A1 (es) | 2014-09-23 | 2015-09-23 | Vacunas recombinantes contra el virus de la fiebre aftosa (fmdv) y sus usos |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10010605B2 (OSRAM) |
| EP (1) | EP3197486A1 (OSRAM) |
| JP (1) | JP6931327B2 (OSRAM) |
| KR (1) | KR102526219B1 (OSRAM) |
| CN (1) | CN107073100B (OSRAM) |
| AP (1) | AP2017009834A0 (OSRAM) |
| AR (1) | AR102006A1 (OSRAM) |
| AU (2) | AU2015320673B2 (OSRAM) |
| CA (1) | CA2962225A1 (OSRAM) |
| JO (1) | JO3600B1 (OSRAM) |
| MA (1) | MA40151B2 (OSRAM) |
| MX (1) | MX388708B (OSRAM) |
| RU (1) | RU2745373C2 (OSRAM) |
| TW (1) | TWI733653B (OSRAM) |
| WO (1) | WO2016049209A1 (OSRAM) |
| ZA (1) | ZA201701851B (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10391163B2 (en) | 2015-09-10 | 2019-08-27 | Academia Sinica | Bird flu vaccine combination comprising virus-like particles and novel adjuvants |
| CN108367067B (zh) | 2015-11-23 | 2022-05-03 | 勃林格殷格翰动物保健美国公司 | Fmdv和e2的融合蛋白质及其用途 |
| TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
| US10172933B2 (en) | 2016-10-31 | 2019-01-08 | The United States Of America, As Represented By The Secretary Of Agriculture | Mosaic vaccines for serotype a foot-and-mouth disease virus |
| CA3068052A1 (en) * | 2017-07-12 | 2019-01-17 | Boheringer Ingelheim Animal Health Usa Inc. | Senecavirus a immunogenic compositions and methods thereof |
| CN108103034B (zh) * | 2017-12-15 | 2022-06-24 | 云南农业大学动物医学院 | 同时表达A型、O型和Asia-1型口蹄疫病毒VP1基因重组腺病毒、构建方法及应用 |
| CN108530522B (zh) * | 2018-03-14 | 2021-09-17 | 中华人民共和国汕头海关 | 一种重组的OmpK多表位多肽、构建方法及其应用 |
| CN110467654B (zh) * | 2018-05-11 | 2022-08-09 | 普莱柯生物工程股份有限公司 | 口蹄疫病毒样颗粒抗原、其制备的疫苗组合物及其制备方法和应用 |
| CN111233984B (zh) * | 2018-11-29 | 2022-08-12 | 普莱柯生物工程股份有限公司 | 一种o型口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用 |
| WO2020147015A1 (zh) * | 2019-01-15 | 2020-07-23 | 普莱柯生物工程股份有限公司 | 口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用 |
| CN114423779B (zh) * | 2019-06-28 | 2024-07-02 | 株式会社准绳生命科学 | 口蹄疫病毒疫苗组合物 |
| AR123873A1 (es) * | 2020-10-22 | 2023-01-18 | Intervet Int Bv | Vector de expresión de baculovirus |
| AU2021363613A1 (en) * | 2020-10-22 | 2023-05-11 | Intervet International B.V. | Baculovirus expression vector |
| US12453767B2 (en) | 2021-08-18 | 2025-10-28 | The United States Of America, As Represented By The Secretary Of Agriculture | Development of mosaic vaccines against foot and mouth disease virus serotype O |
| WO2023020737A1 (en) * | 2021-08-20 | 2023-02-23 | Intervet International B.V. | Fmdv virus-like particle with stabilizing mutation |
| EP4387663A1 (en) * | 2021-08-20 | 2024-06-26 | Intervet International B.V. | Method of producing a foot and mouth disease virus virus-like particle |
| IL310905A (en) * | 2021-08-20 | 2024-04-01 | Intervet Int Bv | A method for producing a virus-like particle for foot-and-mouth disease virus |
| EP4387665A1 (en) * | 2021-08-20 | 2024-06-26 | The Pirbright Institute | Fmdv virus-like particle with double stabilizing mutation |
| KR102513632B1 (ko) * | 2021-11-30 | 2023-03-28 | 주식회사 왓슨알앤디 | 구제역 바이러스 유사 입자를 생산하기 위한 백신 플랫폼 |
| US12036318B2 (en) * | 2022-02-16 | 2024-07-16 | Chemical & Schutz High Performance Lubricants, S.A. De C.V. | Self-emulsionable mineral oil as a vehicle in vaccines for poultry |
| JP2025538585A (ja) * | 2022-11-23 | 2025-11-28 | オプティファーム カンパニー リミテッド | 口蹄疫ウィルス様粒子またはナノ粒子生産のための組換え発現ベクターおよびこれを用いたワクチン組成物 |
| KR20240087552A (ko) | 2022-11-23 | 2024-06-19 | 주식회사 옵티팜 | 구제역 바이러스 유사 입자 또는 나노입자 생산을 위한 재조합 발현 벡터 및 이를 이용한 백신 조성물 |
| CN117210501B (zh) * | 2023-09-13 | 2024-06-07 | 中国农业科学院兰州兽医研究所 | 口蹄疫病毒2b蛋白免疫抑制位点突变的重组口蹄疫病毒株的构建 |
| CN117304277B (zh) * | 2023-09-26 | 2024-03-08 | 中国农业科学院兰州兽医研究所 | 一种o型口蹄疫病毒vp4蛋白t细胞表位多肽及其应用 |
| US20250134984A1 (en) * | 2023-10-26 | 2025-05-01 | The United States Of America, As Represented By The Secretary Of Agriculture | Development of mosaic vaccines against foot and mouth disease virus serotype asia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA915593B (en) | 1990-07-24 | 1993-03-31 | Novagene Inc | Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same |
| FR2810888B1 (fr) * | 2000-06-29 | 2004-07-30 | Merial Sas | Vaccin contre la fievre aphteuse |
| PL1773387T3 (pl) * | 2004-06-25 | 2013-10-31 | Merial Inc | Rekombinanty wirusa ospy ptasiej wyrażające geny wirusa pryszczycy |
| BRPI0618441B8 (pt) | 2005-11-10 | 2021-07-27 | Genvec Inc | vetor adenoviral |
| JP5309159B2 (ja) * | 2008-01-09 | 2013-10-09 | コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション | バキュロウイルスを利用したワクチン |
| CN101270155B (zh) * | 2008-05-06 | 2011-04-27 | 中国农业科学院兰州兽医研究所 | 通过耐酸性改造在昆虫中组装口蹄疫病毒空衣壳的方法 |
| GB0810710D0 (en) * | 2008-06-11 | 2008-07-16 | Animal Health Inst | Vaccine |
| NZ702145A (en) * | 2010-03-12 | 2016-03-31 | Merial Inc | Bluetongue virus recombinant vaccines and uses thereof |
| WO2012158613A1 (en) * | 2011-05-13 | 2012-11-22 | Novartis Ag | Pre-fusion rsv f antigens |
| GB201111183D0 (en) * | 2011-06-30 | 2011-08-17 | Animal Health Inst | Peptide |
| US20150183835A1 (en) * | 2012-06-18 | 2015-07-02 | Novartis Ag | Stabilized gp120 |
| US9738689B2 (en) * | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
-
2015
- 2015-09-23 CA CA2962225A patent/CA2962225A1/en active Pending
- 2015-09-23 US US14/863,181 patent/US10010605B2/en active Active
- 2015-09-23 KR KR1020177010941A patent/KR102526219B1/ko active Active
- 2015-09-23 MA MA40151A patent/MA40151B2/fr unknown
- 2015-09-23 EP EP15775553.9A patent/EP3197486A1/en active Pending
- 2015-09-23 WO PCT/US2015/051755 patent/WO2016049209A1/en not_active Ceased
- 2015-09-23 RU RU2017113571A patent/RU2745373C2/ru active
- 2015-09-23 CN CN201580057248.4A patent/CN107073100B/zh active Active
- 2015-09-23 AU AU2015320673A patent/AU2015320673B2/en active Active
- 2015-09-23 AR ARP150103061A patent/AR102006A1/es active IP Right Grant
- 2015-09-23 TW TW104131548A patent/TWI733653B/zh active
- 2015-09-23 AP AP2017009834A patent/AP2017009834A0/en unknown
- 2015-09-23 MX MX2017003712A patent/MX388708B/es unknown
- 2015-09-23 JP JP2017516077A patent/JP6931327B2/ja active Active
- 2015-09-28 JO JOP/2015/0240A patent/JO3600B1/ar active
-
2017
- 2017-03-15 ZA ZA2017/01851A patent/ZA201701851B/en unknown
-
2019
- 2019-07-30 AU AU2019210537A patent/AU2019210537A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017005833A8 (pt) | 2023-02-14 |
| CA2962225A1 (en) | 2016-03-31 |
| AP2017009834A0 (en) | 2017-03-31 |
| AU2019210537A1 (en) | 2019-08-15 |
| CN107073100A (zh) | 2017-08-18 |
| BR112017005833A2 (pt) | 2018-02-27 |
| JP2017530124A (ja) | 2017-10-12 |
| TWI733653B (zh) | 2021-07-21 |
| US20160220659A1 (en) | 2016-08-04 |
| RU2017113571A3 (OSRAM) | 2019-04-22 |
| WO2016049209A1 (en) | 2016-03-31 |
| MA40151A1 (fr) | 2018-01-31 |
| JP6931327B2 (ja) | 2021-09-01 |
| EP3197486A1 (en) | 2017-08-02 |
| KR20170058430A (ko) | 2017-05-26 |
| JO3600B1 (ar) | 2020-07-05 |
| AU2015320673B2 (en) | 2019-05-02 |
| RU2017113571A (ru) | 2018-10-26 |
| CN107073100B (zh) | 2021-02-26 |
| TW201625297A (zh) | 2016-07-16 |
| AU2015320673A1 (en) | 2017-05-11 |
| MX388708B (es) | 2025-03-20 |
| MX2017003712A (es) | 2017-06-28 |
| KR102526219B1 (ko) | 2023-04-26 |
| MA40151B2 (fr) | 2022-12-30 |
| ZA201701851B (en) | 2018-05-30 |
| US10010605B2 (en) | 2018-07-03 |
| RU2745373C2 (ru) | 2021-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR102006A1 (es) | Vacunas recombinantes contra el virus de la fiebre aftosa (fmdv) y sus usos | |
| AR089039A1 (es) | Vectores recombinantes de hvt que expresan antigenos de patogenos de aves y sus usos | |
| CL2018000740A1 (es) | Vectores del factor viii del virus adeno-asociado, partículas víricas asociadas y formulaciones terapéuticas que los comprenden | |
| AR110632A1 (es) | Vectores del adenovirus canino | |
| UY37100A (es) | Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas | |
| MX2021006931A (es) | Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos. | |
| DOP2012000187A (es) | Antigeno ndv recombinante y usos del mismo | |
| AR080515A1 (es) | Vacunas recombinantes del virus de la enfermedad del pie y de la boca (fmd1) y sus usos | |
| AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
| UY36995A (es) | Proteínas de fusión de e2 y fmdv y sus usos | |
| CL2017003341A1 (es) | Vectores virales recombinantes que contienen la proteína menor del virus del síndrome reproductor y respiratorio porcino (prrsv) y sus métodos de elaboración y uso | |
| EA201400912A1 (ru) | Рекомбинантные поксвирусные векторы, экспрессирующие белки вируса бешенства и ox40, и вакцины, созданные на их основе | |
| MX344103B (es) | Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle. | |
| CL2015002741A1 (es) | Composiciones y métodos para aumentar la respuesta inmune contra patógenos entéricos | |
| CO2017001614A2 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
| AR108014A1 (es) | Vacuna universal para enfermedades virales y método de vacunación | |
| AR109540A1 (es) | Moléculas promotoras para expresar antígenos virales | |
| EA202092164A1 (ru) | Новый ehv с инактивированным ul18 и/или ul8 | |
| AR105819A1 (es) | Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos | |
| UY36328A (es) | Vacunas de fmdv recombinante y usos de las mismas | |
| AR130028A2 (es) | Vectores recombinantes de herpesvirus 3 gálido (mdv serotipo 2) que expresan antígenos de patógenos de aves y sus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |